Drug Trial Radar · NCT06755671
A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms
Last checked: Nov 20, 2026Latest source record: May 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
4,500
Planned (sponsor's estimate)
Start
Apr 30, 2025
Primary completion
Jun 30, 2027
Study completion Jun 30, 2027
Sponsor
- Lead sponsor
- Shanghai Hutchison Pharmaceuticals LimitedIndustry
- Sponsor type
- Industry
- Collaborators
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- First posted
- Jan 1, 2025
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this observational study is to evaluate if Danning Tablets are effective in alleviating dyspepsia in patients with any of the following digestive symptoms: upper abdominal pain, bloating, loss of appetite, acid reflux or constipation. The main questions it aims to answer are: How effective are Danning Tablets for patients with indigestion symptoms? What are the impact factors (e.g. severity of conditions, demographic features, dose and length of treatment etc.) of the efficacy of Danning Tablets for indigestion patients? Participants already taking Danning Tablets as part of their regular medical care for indigestion will take questionnaires by the end of two weeks and four weeks respectively from the start of their treatment.
Conditions
- Indigestion
- Dyspepsia
- Bloating
- Loss of Appetite
- Reflux Acid
- Constipation
- Upper Abdominal Pain
- Functional Dyspepsia
Interventions
Danning TabletDrug
Danning Tablet is the only exposure in this observational study.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Dyspepsia symptoms responder rate post treatmentTime frame: From enrollment to the end of 4 weeks post enrollment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.